Jessica By
Analyst
J.P. Morgan
Equibles does not estimate personal net worth.
About Jessica By
Jessica By is recorded as Analyst at J.P. Morgan. Jessica By has spoken on 1 earnings call across 1 company, most recently for Jazz Pharmaceuticals plc on August 3, 2026. The companies whose calls Jessica By spoke on are classified in the Healthcare sector.
Jessica By on recent calls
“I wanted to ask about ZANI and just hoping you could speak to your confidence and approval heading into the upcoming PDUFA. There had been some talk about the possibility of maybe approval before the PDUFA date.”
Affiliation history
-
J.P. Morgan
Analyst
Transcript header (unverified)
Current